Global Population Genomics Market Anticipated To Grow To $16.34 Billion By 2030 At 14.1% CAGR

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Market Value Expansion Is Expected For The Population Genomics Market Over The Forecast Period?

The population genomics market size has demonstrated rapid expansion over recent years. It is anticipated to grow from $8.44 billion in 2025 to $9.65 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.4%. This historical growth can be attributed to several factors, including the broadening of national genomics initiatives, increased research funding allocated for population studies, development in biobank infrastructure, advancements in sequencing technologies, and a heightened demand for genetic diversity studies.

The population genomics market is projected to experience substantial expansion in the coming years. This market is set to reach $16.34 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.1%. Factors driving this growth during the forecast period include the increasing application of population genomics in personalized medicine, growing investments in global genomics collaborations, the expansion of AI-driven genomic interpretation, the rising utilization of genomics in public health planning, and the increasing adoption of scalable data management systems. Key trends anticipated during the forecast period encompass the increasing deployment of large-scale population sequencing projects, the rising use of advanced variant annotation tools, the growing integration of population genomics with clinical research, the expansion of cloud-based genomics platforms, and an enhanced focus on data standardization.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28305&type=smp

Which Major Factors Are Contributing To The Development Of The Population Genomics Market?

The increasing requirement for personalized medicine is poised to accelerate the expansion of the population genomics market moving forward. Personalized medicine refers to the adaptation of medical interventions based on an individual’s genetic profile. This demand for personalized medicine is escalating as the reduced cost of genomic technologies allows for greater access to targeted therapies. Population genomics assists personalized medicine by uncovering genetic variations common within specific populations, empowering healthcare providers to customize treatments and medications for improved effectiveness and safety according to an individual’s genetic profile. For example, in February 2024, as per the Personalized Medicine Coalition, a US-based non-profit organization, the FDA sanctioned 16 new personalized treatments for rare disease patients in 2023, contrasting with just six approvals in 2022. Thus, the growing demand for personalized medicine is propelling the growth of the population genomics market.

What Are The Core Segment Classifications In The Population Genomics Market?

The population genomics market covered in this report is segmented –

1) By Product And Service: Consumables, Instruments, Services, Software

2) By Sample Type: Human, Animal, Plant, Microbial

3) By Application: Pharmacogenomics, Disease Research, Ancestry And Evolution, Personalized Medicine, Other Applications

4) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Clinics, Other End-Users

Subsegments:

1) By Consumables: Reagents, Kits, Probes And Assay Panels, Enzymes, Buffers And Media, Sample Collection And Storage Materials

2) By Instruments: Sequencers, PCR And qPCR Instruments, Microarray Platforms, Sample Preparation And Extraction Instruments, Imaging Systems, Automation And Robotics Systems

3) By Services: Sequencing Services, Genotyping Services, Bioinformatics And Data Analysis Services, Sample Preparation Services, Custom Assay Development

4) By Software: Data Analysis Software, Genome Assembly Software, Variant Calling And Annotation Software, Cloud-Based Genomics Platforms, Laboratory Information Management Systems (LIMS)

Which Trends Are Influencing The Expansion Of The Population Genomics Market?

Major entities operating within the Pompe disease market are concentrating on strategic collaborations to foster product innovation, broaden market reach, and refine animal health solutions. Such a strategic partnership typically signifies a cooperative arrangement between two or more organizations that merge their assets, specialized knowledge, and efforts to attain mutual aims or objectives. For example, in June 2024, Shionogi & Company, Limited, a Japanese pharmaceutical enterprise, inked a global licensing agreement with Maze Therapeutics, a US-based biotechnology firm, regarding MZE001, an oral investigational drug intended for Pompe disease. Shionogi obtained exclusive rights to MZE001 and its associated intellectual property for an initial payment of $150 million, alongside potential milestone and royalty payments. This agreement was concluded after the mandatory 30-day review period mandated by U.S. antitrust law (HSR Act).

Who Are The Major Companies Operating In The Population Genomics Market?

Major companies operating in the population genomics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Labcorp Holdings Inc., Regeneron Pharmaceuticals Inc., Eurofins Scientific SE, Illumina Inc., Charles River Laboratories, Bio-Rad Laboratories Inc., QIAGEN N.V., Myriad Genetics Inc., Takara Bio Inc, BGI Genomics Co. Ltd., Invitae Corporation, 23andMe Inc., Color Genomics Inc., Helix OpCo LLC, Personalis Inc., Centogene N.V., Genomics England Limited, Veritas Genetics Inc., Genuity Science, Gene by Gene Ltd., Nebula Genomics Inc., Ancestry.com LLC.

Access The Complete Population Genomics Market Report:

https://www.thebusinessresearchcompany.com/report/population-genomics-global-market-report

Which Region Is The Dominant Market In The Population Genomics Market?

North America was the largest region in the population genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the population genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Population Genomics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=28305&type=smp

Browse Through More Reports Similar to the Global Population Genomics Market 2026, By The Business Research Company

Gestational Trophoblastic Disease Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/gestational-trophoblastic-disease-global-market-report

Poc Medical Imaging Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/poc-medical-imaging-global-market-report

Primary Care Poc Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/primary-care-poc-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795